These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29330472)

  • 41. Characterization of Non-amyloidogenic G101S Transthyretin.
    Wakita Y; Sato T; Chosa K; Suico MA; Sasaki R; Kawano S; Hashimoto N; Teranishi Y; Imai Y; Morioka H; Shuto T; Kai H
    Biol Pharm Bull; 2018; 41(4):628-636. PubMed ID: 29607936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum transthyretin monomer in patients with familial amyloid polyneuropathy.
    Sekijima Y; Tokuda T; Kametani F; Tanaka K; Maruyama K; Ikeda S
    Amyloid; 2001 Dec; 8(4):257-62. PubMed ID: 11791618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis.
    Misumi Y; Ando Y; Gonçalves NP; Saraiva MJ
    Lab Invest; 2013 Aug; 93(8):911-20. PubMed ID: 23817086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of an allosteric model to describe the interactions among retinol binding protein 4, transthyretin, and small molecule retinol binding protein 4 ligands.
    Coward P; Conn M; Tang J; Xiong F; Menjares A; Reagan JD
    Anal Biochem; 2009 Jan; 384(2):312-20. PubMed ID: 18952041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.
    Sekijima Y; Dendle MA; Kelly JW
    Amyloid; 2006 Dec; 13(4):236-49. PubMed ID: 17107884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
    Penchala SC; Connelly S; Wang Y; Park MS; Zhao L; Baranczak A; Rappley I; Vogel H; Liedtke M; Witteles RM; Powers ET; Reixach N; Chan WK; Wilson IA; Kelly JW; Graef IA; Alhamadsheh MM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9992-7. PubMed ID: 23716704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The discovery and development of transthyretin amyloidogenesis inhibitors: what are the lessons?
    Zhong B; Huang X; Zheng Y; Guo X; Wu L
    Future Med Chem; 2021 Dec; 13(23):2083-2105. PubMed ID: 34633220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid.
    Yazaki M; Liepnieks JJ; Kincaid JC; Benson MD
    Muscle Nerve; 2003 Oct; 28(4):438-42. PubMed ID: 14506715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    J Neuropathol Exp Neurol; 2015 Mar; 74(3):203-17. PubMed ID: 25668561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single AAV-mediated CRISPR-Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosis.
    Wen J; Cao T; Wu J; Chen Y; Zhi S; Huang Y; Zhen P; Wu G; Aagaard L; Zhong J; Liang P; Huang J
    Mol Ther; 2022 Jan; 30(1):164-174. PubMed ID: 33992807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy.
    Ackermann EJ; Guo S; Booten S; Alvarado L; Benson M; Hughes S; Monia BP
    Amyloid; 2012 Jun; 19 Suppl 1():43-4. PubMed ID: 22494066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
    Liang Y; Ore MO; Morin S; Wilson DJ
    Biochemistry; 2012 Apr; 51(16):3523-30. PubMed ID: 22482799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrasting effects of type 2 and type 1 diabetes on plasma RBP4 levels: the significance of transthyretin.
    Pullakhandam R; Palika R; Ghosh S; Reddy GB
    IUBMB Life; 2012 Dec; 64(12):975-82. PubMed ID: 23129325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses.
    De Lillo A; De Angelis F; Di Girolamo M; Luigetti M; Frusconi S; Manfellotto D; Fuciarelli M; Polimanti R
    Hum Genet; 2019 Dec; 138(11-12):1331-1340. PubMed ID: 31659433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ALTERED CIRCULATING LEVELS OF RETINOL BINDING PROTEIN 4 AND TRANSTHYRETIN IN RELATION TO INSULIN RESISTANCE, OBESITY, AND GLUCOSE INTOLERANCE IN ASIAN INDIANS.
    Pandey GK; Balasubramanyam J; Balakumar M; Deepa M; Anjana RM; Abhijit S; Kaviya A; Velmurugan K; Miranda P; Balasubramanyam M; Mohan V; Gokulakrishnan K
    Endocr Pract; 2015 Aug; 21(8):861-9. PubMed ID: 26121433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
    Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease.
    Klimtchuk ES; Prokaeva T; Frame NM; Abdullahi HA; Spencer B; Dasari S; Cui H; Berk JL; Kurtin PJ; Connors LH; Gursky O
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6428-E6436. PubMed ID: 29941560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific pathogen free conditions prevent transthyretin amyloidosis in mouse models.
    Inoue S; Ohta M; Li Z; Zhao G; Takaoka Y; Sakashita N; Miyakawa K; Takada K; Tei H; Suzuki M; Masuoka M; Sakaki Y; Takahashi K; Yamamura K
    Transgenic Res; 2008 Oct; 17(5):817-26. PubMed ID: 18357510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.